Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Osteoporosis

  Free Subscription


Articles published in Osteoporos Int

Retrieve available abstracts of 447 articles:
HTML format
Text format



Single Articles


    May 2017
  1. LIN YC, Huang TS, Wu JS, Cheung YC, et al
    Are bilateral decubitus views necessary in assessing for vertebral compression fractures using DXA vertebral fracture assessment?
    Osteoporos Int. 2017 May 9. doi: 10.1007/s00198-017-4040.
    PubMed     Text format     Abstract available


  2. LAIRD E, Molloy AM, McNulty H, Ward M, et al
    Greater yogurt consumption is associated with increased bone mineral density and physical function in older adults.
    Osteoporos Int. 2017 May 1. doi: 10.1007/s00198-017-4049.
    PubMed     Text format     Abstract available


    April 2017
  3. KANIS JA, Cooper C, Rizzoli R, Abrahamsen B, et al
    Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting.
    Osteoporos Int. 2017 Apr 27. doi: 10.1007/s00198-017-4009.
    PubMed     Text format     Abstract available


  4. HASEGAWA T, Kawakita A, Ueda N, Funahara R, et al
    A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRO
    Osteoporos Int. 2017 Apr 27. doi: 10.1007/s00198-017-4063.
    PubMed     Text format     Abstract available


  5. MCCLOSKEY EV
    Identification of vertebral fractures: a moderately severe solution?
    Osteoporos Int. 2017 Apr 27. doi: 10.1007/s00198-017-4042.
    PubMed     Text format    


  6. LI C, Zeng Y, Tao L, Liu S, et al
    Meta-analysis of hypertension and osteoporotic fracture risk in women and men.
    Osteoporos Int. 2017 Apr 26. doi: 10.1007/s00198-017-4050.
    PubMed     Text format     Abstract available


  7. CLARK EM, Cummings SR, Schousboe JT
    Spinal radiographs in those with back pain-when are they appropriate to diagnose vertebral fractures?
    Osteoporos Int. 2017 Apr 25. doi: 10.1007/s00198-017-4052.
    PubMed     Text format     Abstract available


  8. GUAN Y, Lv F, Meng Y, Ma D, et al
    Association between bone mineral density, muscle strength, and vitamin D status in patients with myasthenia gravis: a cross-sectional study.
    Osteoporos Int. 2017 Apr 24. doi: 10.1007/s00198-017-4041.
    PubMed     Text format     Abstract available


  9. MOBERG L, Nilsson PM, Samsioe G, Sallsten G, et al
    Increased blood cadmium levels were not associated with increased fracture risk but with increased total mortality in women: the Malmo Diet and Cancer Study.
    Osteoporos Int. 2017 Apr 21. doi: 10.1007/s00198-017-4047.
    PubMed     Text format     Abstract available


  10. DOMBROWSKI S, Jacob L, Hadji P, Kostev K, et al
    Oral contraceptive use and fracture risk-a retrospective study of 12,970 women in the UK.
    Osteoporos Int. 2017 Apr 13. doi: 10.1007/s00198-017-4036.
    PubMed     Text format     Abstract available


  11. SATO H, Kondo N, Nakatsue T, Wada Y, et al
    High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates.
    Osteoporos Int. 2017 Apr 13. doi: 10.1007/s00198-017-4038.
    PubMed     Text format     Abstract available


  12. RODRIGUEZ AJ, Scott D, Hodge A, English DR, et al
    Associations between hip bone mineral density, aortic calcification and cardiac workload in community-dwelling older Australians.
    Osteoporos Int. 2017 Apr 4. doi: 10.1007/s00198-017-4024.
    PubMed     Text format     Abstract available


    March 2017
  13. GALLI S, Stocchero M, Andersson M, Karlsson J, et al
    The effect of magnesium on early osseointegration in osteoporotic bone: a histological and gene expression investigation.
    Osteoporos Int. 2017 Mar 27. doi: 10.1007/s00198-017-4004.
    PubMed     Text format     Abstract available


  14. WU J, Xu L, Lv Y, Dong L, et al
    Quantitative analysis of efficacy and associated factors of calcium intake on bone mineral density in postmenopausal women.
    Osteoporos Int. 2017 Mar 23. doi: 10.1007/s00198-017-3993.
    PubMed     Text format     Abstract available


  15. CHEN YY, Feng JY, Ting WY, Yen YF, et al
    Increased risk of incident osteoporosis and osteoporotic fracture in tuberculosis patients: a population-based study in a tuberculosis-endemic area.
    Osteoporos Int. 2017 Mar 22. doi: 10.1007/s00198-017-3939.
    PubMed     Text format     Abstract available


  16. MORIWAKI K, Mouri M, Hagino H
    Erratum to: Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan.
    Osteoporos Int. 2017 Mar 21. doi: 10.1007/s00198-017-4006.
    PubMed     Text format    


  17. LAINE CM, Landin-Wilhelmsen K
    Case report: fast reversal of severe osteoporosis after correction of excessive levothyroxine treatment and long-term follow-up.
    Osteoporos Int. 2017 Mar 21. doi: 10.1007/s00198-017-3981.
    PubMed     Text format     Abstract available


  18. THOMPSON MJ, Aitken DA, Otahal P, Cicolini J, et al
    The relationship between cumulative lifetime ultraviolet radiation exposure, bone mineral density, falls risk and fractures in older adults.
    Osteoporos Int. 2017 Mar 20. doi: 10.1007/s00198-017-4001.
    PubMed     Text format     Abstract available


  19. LOOKER AC, Sarafrazi Isfahani N, Fan B, Shepherd JA, et al
    Trends in osteoporosis and low bone mass in older US adults, 2005-2006 through 2013-2014.
    Osteoporos Int. 2017 Mar 18. doi: 10.1007/s00198-017-3996.
    PubMed     Text format     Abstract available


  20. MOHD-TAHIR NA, Li SC
    Economic burden of osteoporosis-related hip fracture in Asia: a systematic review.
    Osteoporos Int. 2017 Mar 17. doi: 10.1007/s00198-017-3985.
    PubMed     Text format     Abstract available


  21. ASADIPOOYA K, Graves L, Greene LW
    Transient osteoporosis of the hip: review of the literature.
    Osteoporos Int. 2017 Mar 17. doi: 10.1007/s00198-017-3952.
    PubMed     Text format     Abstract available


  22. POPP AW, Senn R, Curkovic I, Senn C, et al
    Factors associated with acute-phase response of bisphosphonate-naive or pretreated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate.
    Osteoporos Int. 2017 Mar 15. doi: 10.1007/s00198-017-3992.
    PubMed     Text format     Abstract available


  23. CHANG HK, Chang DG, Myong JP, Kim JH, et al
    Bone mineral density among Korean females aged 20-50 years: influence of age at menarche (The Korea National Health and Nutrition Examination Survey 2008-2011).
    Osteoporos Int. 2017 Mar 14. doi: 10.1007/s00198-017-3997.
    PubMed     Text format     Abstract available


  24. EASTELL R, Diez-Perez A
    Recommendations for the screening of adherence to oral bisphosphonates: reply to comments by Zhou and Sheng.
    Osteoporos Int. 2017 Mar 10. doi: 10.1007/s00198-017-3991.
    PubMed     Text format    


  25. ZHOU YH, Sheng ZF
    Comments on Diez-Perez et al.: Recommendations for the screening of adherence to oral bisphosphonates.
    Osteoporos Int. 2017 Mar 10. doi: 10.1007/s00198-017-3987.
    PubMed     Text format    


  26. MAJUMDAR SR, Lier DA, Hanley DA, Juby AG, et al
    Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the "Catch a Break" 1i [type C] FLS.
    Osteoporos Int. 2017 Mar 9. doi: 10.1007/s00198-017-3986.
    PubMed     Text format     Abstract available


  27. IMAI T, Tanaka S, Kawakami K, Miyazaki T, et al
    Health state utility values and patient-reported outcomes before and after vertebral and non-vertebral fractures in an osteoporosis clinical trial.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3966.
    PubMed     Text format     Abstract available


  28. MORIWAKI K, Mouri M, Hagino H
    Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3973.
    PubMed     Text format     Abstract available


  29. KERR C, Bottomley C, Shingler S, Giangregorio L, et al
    The importance of physical function to people with osteoporosis.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3911.
    PubMed     Text format     Abstract available


  30. HAN MH, Ryu JI, Kim CH, Kim JM, et al
    Influence of systemic bone mineral density on atlantoaxial subluxation in patients with rheumatoid arthritis.
    Osteoporos Int. 2017 Mar 2. doi: 10.1007/s00198-017-3972.
    PubMed     Text format     Abstract available


  31. WEI Y, Tian W, Zhang GL, Lv YW, et al
    Thoracolumbar kyphosis is associated with compressive vertebral fracture in postmenopausal women.
    Osteoporos Int. 2017 Mar 1. doi: 10.1007/s00198-017-3971.
    PubMed     Text format     Abstract available


    February 2017
  32. TAMAKI J, Iki M, Sato Y, Kajita E, et al
    Total 25-hydroxyvitamin D levels predict fracture risk: results from the 15-year follow-up of the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
    Osteoporos Int. 2017 Feb 27. doi: 10.1007/s00198-017-3967.
    PubMed     Text format     Abstract available


  33. DU Y, Zhao LJ, Xu Q, Wu KH, et al
    Socioeconomic status and bone mineral density in adults by race/ethnicity and gender: the Louisiana osteoporosis study.
    Osteoporos Int. 2017 Feb 24. doi: 10.1007/s00198-017-3951.
    PubMed     Text format     Abstract available


  34. MORFELD JC, Vennedey V, Muller D, Pieper D, et al
    Patient education in osteoporosis prevention: a systematic review focusing on methodological quality of randomised controlled trials.
    Osteoporos Int. 2017 Feb 24. doi: 10.1007/s00198-017-3946.
    PubMed     Text format     Abstract available


  35. ROUX C, Briot K
    Imminent fracture risk.
    Osteoporos Int. 2017 Feb 24. doi: 10.1007/s00198-017-3976.
    PubMed     Text format     Abstract available


  36. LEE SH, Hsu WT, Lai CC, Esmaily-Fard A, et al
    Erratum to: Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Feb 23. doi: 10.1007/s00198-017-3938.
    PubMed     Text format    


  37. MORI T, Crandall CJ, Ganz DA
    Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan.
    Osteoporos Int. 2017 Feb 17. doi: 10.1007/s00198-017-3940.
    PubMed     Text format     Abstract available


  38. COLARES NETO GP, Pereira RM, Alvarenga JC, Takayama L, et al
    Evaluation of bone mineral density and microarchitectural parameters by DXA and HR-pQCT in 37 children and adults with X-linked hypophosphatemic rickets.
    Osteoporos Int. 2017 Feb 13. doi: 10.1007/s00198-017-3949.
    PubMed     Text format     Abstract available


  39. DEDE AD, Trovas G, Chronopoulos E, Triantafyllopoulos IK, et al
    Response to: A role for thiazide diuretic therapy in preventing bone loss, fracture and nephrolithiasis in individuals with thalassemia and hypercalciuria?
    Osteoporos Int. 2017 Feb 13. doi: 10.1007/s00198-017-3927.
    PubMed     Text format    


  40. MORTON A
    A role for thiazide diuretic therapy in preventing bone loss, fracture, and nephrolithiasis in individuals with thalassemia and hypercalciuria?
    Osteoporos Int. 2017 Feb 13. doi: 10.1007/s00198-017-3922.
    PubMed     Text format    


  41. LEE DY, Jee JH, Cho YY, Jang JY, et al
    Serum 25-hydroxyvitamin D cutoffs for functional bone measures in postmenopausal osteoporosis.
    Osteoporos Int. 2017 Feb 10. doi: 10.1007/s00198-016-3892.
    PubMed     Text format     Abstract available


  42. BALLANE G, Cauley JA, Luckey MM, El-Hajj Fuleihan G, et al
    Worldwide prevalence and incidence of osteoporotic vertebral fractures.
    Osteoporos Int. 2017 Feb 6. doi: 10.1007/s00198-017-3909.
    PubMed     Text format     Abstract available


  43. LESPESSAILLES E, Cortet B, Legrand E, Guggenbuhl P, et al
    Low-trauma fractures without osteoporosis.
    Osteoporos Int. 2017 Feb 4. doi: 10.1007/s00198-017-3921.
    PubMed     Text format     Abstract available


  44. MIKULA AL, Hetzel SJ, Binkley N, Anderson PA, et al
    Validity of height loss as a predictor for prevalent vertebral fractures, low bone mineral density, and vitamin D deficiency.
    Osteoporos Int. 2017 Feb 3. doi: 10.1007/s00198-017-3937.
    PubMed     Text format     Abstract available


    January 2017
  45. FU SJ, Sheng ZF
    Comments on Kamimura et al.: significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients.
    Osteoporos Int. 2017 Jan 27. doi: 10.1007/s00198-016-3867.
    PubMed     Text format    


  46. KAMIMURA M, Nakamura Y, Ikegami S, Uchiyama S, et al
    Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients: response to comments.
    Osteoporos Int. 2017 Jan 27. doi: 10.1007/s00198-017-3923.
    PubMed     Text format    


  47. OKUBO R, Sanada LS, Castania VA, Louzada MJ, et al
    Jumping exercise preserves bone mineral density and mechanical properties in osteopenic ovariectomized rats even following established osteopenia.
    Osteoporos Int. 2017 Jan 26. doi: 10.1007/s00198-017-3905.
    PubMed     Text format     Abstract available


  48. ALACREU E, Moratal D, Arana E
    Opportunistic screening for osteoporosis by routine CT in Southern Europe.
    Osteoporos Int. 2017 Jan 20. doi: 10.1007/s00198-016-3804.
    PubMed     Text format     Abstract available


  49. DIEZ-PEREZ A, Naylor KE, Abrahamsen B, Agnusdei D, et al
    International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates.
    Osteoporos Int. 2017 Jan 16. doi: 10.1007/s00198-017-3906.
    PubMed     Text format     Abstract available


  50. HONG AR, Kim JH, Lee KH, Kim TY, et al
    Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer.
    Osteoporos Int. 2017 Jan 12. doi: 10.1007/s00198-016-3899.
    PubMed     Text format     Abstract available


  51. LIM Y, Jo K, Ha HS, Yim HW, et al
    The prevalence of osteoporosis and the rate of bone loss in Korean adults: the Chungju metabolic disease cohort (CMC) study.
    Osteoporos Int. 2017 Jan 12. doi: 10.1007/s00198-016-3893.
    PubMed     Text format     Abstract available


  52. LEE SH, Hsu WT, Lai CC, Amin EF, et al
    Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Jan 12. doi: 10.1007/s00198-016-3881.
    PubMed     Text format     Abstract available


  53. HADJI P, Boekhoff J, Hahn M, Hellmeyer L, et al
    Pregnancy-associated osteoporosis: a case-control study.
    Osteoporos Int. 2017 Jan 10. doi: 10.1007/s00198-016-3897.
    PubMed     Text format     Abstract available


  54. MODI A, Sajjan S, Insinga R, Weaver J, et al
    Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2 years.
    Osteoporos Int. 2017 Jan 5. doi: 10.1007/s00198-016-3886.
    PubMed     Text format     Abstract available


    December 2016
  55. JOHANSSON H, Siggeirsdottir K, Harvey NC, Oden A, et al
    Imminent risk of fracture after fracture.
    Osteoporos Int. 2016 Dec 27. doi: 10.1007/s00198-016-3868.
    PubMed     Text format     Abstract available


  56. MANA DL, Zanchetta MB, Zanchetta JR
    Retreatment with teriparatide: our experience in three patients with severe secondary osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  57. WRIGHT NC, Saag KG, Dawson-Hughes B, Khosla S, et al
    The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  58. FECHTENBAUM J, Kolta S, Briot K, Roux C, et al
    Vertebral fracture assessment by dual X-ray absorptiometry.
    Osteoporos Int. 2016.
    PubMed     Text format    


  59. RUD B, Hyldstrup L
    Vertebral fracture assessment by dual X-ray absorptiometry: reply to comments by Fechtenbaum et al.
    Osteoporos Int. 2016.
    PubMed     Text format    


  60. OTA M, Takahata M, Shimizu T, Kanehira Y, et al
    Efficacy and safety of osteoporosis medications in a rat model of late-stage chronic kidney disease accompanied by secondary hyperparathyroidism and hyperphosphatemia.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  61. CHEN GD, Ding D, Tian HY, Zhu YY, et al
    Adherence to the 2006 American Heart Association's Diet and Lifestyle Recommendations for cardiovascular disease risk reduction is associated with bone mineral density in older Chinese.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  62. CORREA CB, Camargos GV, Chatterjee M, Mesquita MF, et al
    Can the alendronate dosage be altered when combined with high-frequency loading in osteoporosis treatment?
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  63. CIRNIGLIARO CM, Myslinski MJ, La Fountaine MF, Kirshblum SC, et al
    Bone loss at the distal femur and proximal tibia in persons with spinal cord injury: imaging approaches, risk of fracture, and potential treatment options.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  64. JAMAL SA, Reid LS, Hamilton CJ
    Statement of concern re: The effects of organic nitrates on osteoporosis: a systematic review.
    Osteoporos Int. 2016.
    PubMed     Text format    


  65. JAMAL SA, Goltzman D, Hanley DA, Papaioannou A, et al
    Retraction to: Nitrate use and changes in bone mineral density: the Canadian Multicentre Osteoporosis Study.
    Osteoporos Int. 2016.
    PubMed     Text format    


  66. ZHANG J, Hu X, Zhang J
    Associations between serum vitamin E concentration and bone mineral density in the US elderly population.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    November 2016
  67. MAWATARI T, Muraoka R, Iwamoto Y
    Relationship between baseline characteristics and response to risedronate treatment for osteoporosis: data from three Japanese phase III trials.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  68. NOGUCHI T, Ebina K, Hirao M, Morimoto T, et al
    Oxygen ultra-fine bubbles water administration prevents bone loss of glucocorticoid-induced osteoporosis in mice by suppressing osteoclast differentiation.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  69. AN T, Hao J, Sun S, Li R, et al
    Efficacy of statins for osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  70. JACOB L, Kostev K
    Impact of attention deficit hyperactivity disorder therapy on fracture risk in children treated in German pediatric practices.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  71. YOSHIMURA N, Muraki S, Oka H, Iidaka T, et al
    Is osteoporosis a predictor for future sarcopenia or vice versa? Four-year observations between the second and third ROAD study surveys.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  72. SANCHEZ A, Blanco R
    Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  73. KIM H, Baek KH, Lee SY, Ahn SH, et al
    Association of circulating dipeptidyl-peptidase 4 levels with osteoporotic fracture in postmenopausal women.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  74. KRUSE C, Eiken P, Vestergaard P
    Clinical fracture risk evaluated by hierarchical agglomerative clustering.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  75. ZHU W, Shen H, Zhang JG, Zhang L, et al
    Cytosolic proteome profiling of monocytes for male osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  76. RAY R, Clement ND, Aitken SA, McQueen MM, et al
    High mortality in younger patients with major osteoporotic fractures.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  77. GARCIA-HOYOS M, Garcia-Unzueta MT, de Luis D, Valero C, et al
    Diverging results of areal and volumetric bone mineral density in Down syndrome.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  78. MATHAVAN N, Tagil M, Isaksson H
    Do osteoporotic fractures constitute a greater recalcitrant challenge for skeletal regeneration? Investigating the efficacy of BMP-7 and zoledronate treatment of diaphyseal fractures in an open fracture osteoporotic rat model.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available



  79. ABSTRACTS OF OSTEOPOROSIS CONFERENCE 2016.
    Osteoporos Int. 2016;27.
    PubMed     Text format    



  80. IOF Regionals - 6th Asia-Pacific Osteoporosis Meeting : Author index.
    Osteoporos Int. 2016;27.
    PubMed     Text format    



  81. IOF Regionals - 6th Asia-Pacific Osteoporosis Meeting : Plenary Lectures.
    Osteoporos Int. 2016;27.
    PubMed     Text format    



  82. IOF Regionals - 6th Asia-Pacific Osteoporosis Meeting : Oral Communications.
    Osteoporos Int. 2016;27.
    PubMed     Text format    



  83. IOF Regionals - 6th Asia-Pacific Osteoporosis Meeting : Poster Presentations.
    Osteoporos Int. 2016;27.
    PubMed     Text format    


    October 2016
  84. ZERBINI CA, Clark P, Mendez-Sanchez L, Pereira RM, et al
    Biologic therapies and bone loss in rheumatoid arthritis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  85. BEATON DE, Vidmar M, Pitzul KB, Sujic R, et al
    Addition of a fracture risk assessment to a coordinator's role improved treatment rates within 6 months of screening in a fragility fracture screening program.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  86. BELHASSEN M, Confavreux CB, Cortet B, Lamezec L, et al
    Anti-osteoporotic treatments in France: initiation, persistence and switches over 6 years of follow-up.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  87. FINK HA, Litwack-Harrison S, Taylor BC, Bauer DC, et al
    Erratum to: Clinical utility of routine laboratory testing to identify possible secondary causes in older men with osteoporosis: the osteoporotic fractures in men (MrOS) study.
    Osteoporos Int. 2016.
    PubMed     Text format    


  88. HARVEY NC, Biver E, Kaufman JM, Bauer J, et al
    The role of calcium supplementation in healthy musculoskeletal ageing : An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Fo
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  89. TSENTIDIS C, Gourgiotis D, Kossiva L, Marmarinos A, et al
    Increased levels of Dickkopf-1 are indicative of Wnt/beta-catenin downregulation and lower osteoblast signaling in children and adolescents with type 1 diabetes mellitus, contributing to lower bone mineral density.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  90. IKI M, Fujita Y, Tamaki J, Kouda K, et al
    Incident fracture associated with increased risk of mortality even after adjusting for frailty status in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Cohort Study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  91. CHOI HS, Park JH, Kim SH, Shin S, et al
    Strong familial association of bone mineral density between parents and offspring: KNHANES 2008-2011.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  92. YOSHIMURA M, Moriwaki K, Noto S, Takiguchi T, et al
    A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  93. FARMER S, Shanbhogue VV, Hansen S, Stahlberg CI, et al
    Bone mineral density and microarchitecture in patients with essential thrombocythemia and polycythemia vera.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  94. SU Y, Leung J, Hans D, Aubry-Rozier B, et al
    Added clinical use of trabecular bone score to BMD for major osteoporotic fracture prediction in older Chinese people: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  95. MORI T, Crandall CJ, Ganz DA
    Cost-effectiveness of combined oral bisphosphonate therapy and falls prevention exercise for fracture prevention in the USA.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  96. PIRRO M, Mannarino MR, Bianconi V, De Vuono S, et al
    Uric acid and bone mineral density in postmenopausal osteoporotic women: the link lies within the fat.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  97. WALLACE ER, Siscovick DS, Sitlani CM, Dublin S, et al
    Incident atrial fibrillation and the risk of fracture in the cardiovascular health study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  98. RODRIGUES IB, Armstrong JJ, Adachi JD, MacDermid JC, et al
    Facilitators and barriers to exercise adherence in patients with osteopenia and osteoporosis: a systematic review.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  99. KAMYCHEVA E, Goto T, Camargo CA Jr
    Celiac disease is associated with reduced bone mineral density and increased FRAX scores in the US National Health and Nutrition Examination Survey.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  100. MORIWAKI K, Noto S
    Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    September 2016
  101. ATTERITANO M, Di Mauro E, Canale V, Bruzzese AM, et al
    Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  102. XU MH, Li X, Yuan FL
    Is it necessary to investigate rapamycin-modulated autophagy during the development of experimental osteoporosis in female rat?
    Osteoporos Int. 2016.
    PubMed     Text format    


  103. CHAKHTOURA M, Leslie WD, McClung M, Cheung AM, et al
    The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  104. KAMIMURA M, Nakamura Y, Ikegami S, Uchiyama S, et al
    Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  105. AVENELL A, Bolland MJ, Grey A, Reid IR, et al
    Further major uncorrected errors in National Osteoporosis Foundation meta-analyses of calcium and vitamin D supplementation in fracture prevention.
    Osteoporos Int. 2016.
    PubMed     Text format    


  106. SMALLWOOD AJ, Schapira MM, Fedders M, Neuner JM, et al
    A pilot randomized controlled trial of a decision aid with tailored fracture risk tool delivered via a patient portal.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  107. WU X, Wei D, Sun B, Wu XN, et al
    Poor medication adherence to bisphosphonates and high self-perception of aging in elderly female patients with osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  108. BALOGH R, Wood J, Dobranowski K, Lin E, et al
    Low-trauma fractures and bone mineral density testing in adults with and without intellectual and developmental disabilities: a population study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  109. NAKAMURA T, Fukunaga M, Nakano T, Kishimoto H, et al
    Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study).
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  110. CATALANO A, Vita GL, Russo M, Vita G, et al
    Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  111. AUBRY-ROZIER B, Fabreguet I, Iglesias K, Lamy O, et al
    Impact of level of expertise versus the statistical tool on vertebral fracture assessment (VFA) readings in cohort studies.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    August 2016
  112. NI W, Jiang Y
    Evaluation on the cost-effective threshold of osteoporosis treatment on elderly women in China using discrete event simulation model.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  113. TAKAHASHI S, Hoshino M, Takayama K, Iseki K, et al
    Time course of osteoporotic vertebral fractures by magnetic resonance imaging using a simple classification: a multicenter prospective cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  114. DUAN X, Wang J, Jiang X
    A meta-analysis of breastfeeding and osteoporotic fracture risk in the females.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  115. SU Y, Leung J, Hans D, Lamy O, et al
    The added value of trabecular bone score to FRAX(R) to predict major osteoporotic fractures for clinical use in Chinese older people: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  116. BUCHELE G, Becker C, Cameron ID, Auer R, et al
    Fracture risk in people with developmental disabilities: results of a large claims data analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  117. POP LC, Sukumar D, Schneider SH, Schlussel Y, et al
    Three doses of vitamin D, bone mineral density, and geometry in older women during modest weight control in a 1-year randomized controlled trial.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  118. LU PC, Yang YH, Guo SE, Yang TM, et al
    Factors associated with osteoporosis in patients with chronic obstructive pulmonary disease-a nationwide retrospective study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  119. HWANG J, Lee EK, Ahn JK, Cha HS, et al
    Bone-density testing interval and transition to osteoporosis in patients with rheumatoid arthritis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  120. DEDE AD, Trovas G, Chronopoulos E, Triantafyllopoulos IK, et al
    Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  121. CLARK E
    Health-related quality of life in older people with osteoporotic vertebral fractures: response to comments by Sani et al.
    Osteoporos Int. 2016.
    PubMed     Text format    


  122. SANI M, Ayubi E, Khazaei S, Mansori K, et al
    Health-related quality of life in older people with osteoporotic vertebral fractures: clinically important vs. statistically significant.
    Osteoporos Int. 2016.
    PubMed     Text format    


  123. KIM MK, Chon SJ, Noe EB, Roh YH, et al
    Associations of dietary calcium intake with metabolic syndrome and bone mineral density among the Korean population: KNHANES 2008-2011.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  124. SCHOUSBOE JT, Riekkinen O, Karjalainen J
    Prediction of hip osteoporosis by DXA using a novel pulse-echo ultrasound device.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  125. KIM YW, Kim JH, Yoon SH, Lee JH, et al
    Vertebral bone attenuation on low-dose chest CT: quantitative volumetric analysis for bone fragility assessment.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    July 2016
  126. HANSEN L, Petersen KD, Eriksen SA, Gerstoft F, et al
    Subjects with osteoporosis to remain at high risk for fracture despite benefit of prior bisphosphonate treatment-a Danish case-control study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  127. ZHU K, Hunter M, James A, Lim EM, et al
    Discordance between fat mass index and body mass index is associated with reduced bone mineral density in women but not in men: the Busselton Healthy Ageing Study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  128. LO JC, Kim S, Chandra M, Ettinger B, et al
    Applying ethnic-specific bone mineral density T-scores to Chinese women in the USA.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  129. GAO C, Qiao J, Li SS, Yu WJ, et al
    The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  130. KYVERNITAKIS I, Kostev K, Nassour T, Thomasius F, et al
    The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  131. BURR DB
    The use of finite element analysis to estimate the changing strength of bone following treatment for osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format    


  132. WARD J, Wood C, Rouch K, Pienkowski D, et al
    Stiffness and strength of bone in osteoporotic patients treated with varying durations of oral bisphosphonates.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  133. MCCLOSKEY EV, Johansson H, Harvey NC, Compston J, et al
    Access to fracture risk assessment by FRAX and linked National Osteoporosis Guideline Group (NOGG) guidance in the UK-an analysis of anonymous website activity.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  134. QIN W, Zhao W, Li X, Peng Y, et al
    Mice with sclerostin gene deletion are resistant to the severe sublesional bone loss induced by spinal cord injury.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  135. LEWIECKI EM, Boyle JF, Arora S, Bouchonville MF 2nd, et al
    Telementoring: a novel approach to reducing the osteoporosis treatment gap.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  136. WOZNIAK LA, Johnson JA, McAlister FA, Beaupre LA, et al
    Understanding fragility fracture patients' decision-making process regarding bisphosphonate treatment.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  137. MORSE LR, Nguyen N, Battaglino RA, Guarino AJ, et al
    Wheelchair use and lipophilic statin medications may influence bone loss in chronic spinal cord injury: findings from the FRASCI-bone loss study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  138. MORAN JM, Pedrera-Zamorano JD
    Comments on: The effect of prolonged breast-feeding on the development of postmenopausal osteoporosis in population with insufficient calcium intake and vitamin D level.
    Osteoporos Int. 2016.
    PubMed     Text format    


  139. YUN BH, Seo SK
    Response to comments by Moran et al. on: The effect of prolonged breast-feeding on the development of postmenopausal osteoporosis in population with insufficient calcium intake and vitamin D level.
    Osteoporos Int. 2016.
    PubMed     Text format    


  140. WEAVER CM, Dawson-Hughes B, Lappe JM, Wallace TC, et al
    Erratum and additional analyses re: Calcium plus vitamin D supplementation and the risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation.
    Osteoporos Int. 2016.
    PubMed     Text format    


  141. KJELLBERG J, Jorgensen AD, Vestergaard P, Ibsen R, et al
    Cost and health care resource use associated with noncompliance with oral bisphosphonate therapy: an analysis using Danish health registries.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  142. UGURLAR M
    Alendronate- and risedronate-induced acute polyarthritis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    June 2016
  143. LOU Y, Edmonds SW, Jones MP, Ullrich F, et al
    Predictors of bone mineral density testing among older women on Medicare.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  144. CHANG PY, Saechao FS, Lee J, Haskell SG, et al
    Prevalence and risk of fracture diagnoses in women across the adult life span: a national cross-sectional study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  145. TAKAHASHI S, Hoshino M, Takayama K, Iseki K, et al
    Predicting delayed union in osteoporotic vertebral fractures with consecutive magnetic resonance imaging in the acute phase: a multicenter cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  146. AKTAS I, Nazikoglu C, Kepez A, Ozkan FU, et al
    Effect of intravenous zoledronic acid infusion on electrocardiographic parameters in patients with osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  147. MARQUES EA, Gudnason V, Lang T, Sigurdsson G, et al
    Association of bone turnover markers with volumetric bone loss, periosteal apposition, and fracture risk in older men and women: the AGES-Reykjavik longitudinal study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  148. YAGI M, Ohne H, Konomi T, Fujiyoshi K, et al
    Teriparatide improves volumetric bone mineral density and fine bone structure in the UIV+1 vertebra, and reduces bone failure type PJK after surgery for adult spinal deformity.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  149. PEI YF, Xie ZG, Wang XY, Hu WZ, et al
    Association of 3q13.32 variants with hip trochanter and intertrochanter bone mineral density identified by a genome-wide association study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  150. PEREIRA RM, Figueiredo CP, Cha CC, Caparbo VF, et al
    Associations between OPG and RANKL polymorphisms, vertebral fractures, and abdominal aortic calcification in community-dwelling older subjects: the Sao Paulo Ageing & Health Study (SPAH).
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  151. LUCATO P, Trevisan C, Stubbs B, Zanforlini BM, et al
    Nephrolithiasis, bone mineral density, osteoporosis, and fractures: a systematic review and comparative meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  152. BALASUBRAMANIAN A, Wade SW, Adler RA, Lin CJ, et al
    Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  153. ZHOU J, Ma X, Wang T, Zhai S, et al
    Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  154. AL-SARI UA, Tobias J, Clark E
    Health-related quality of life in older people with osteoporotic vertebral fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  155. YEH CB, Weng SJ, Chang KW, Chan JY, et al
    Calcitonin alleviates hyperalgesia in osteoporotic rats by modulating serotonin transporter activity.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  156. BARZILAY JI, Buzkova P, Fink HA, Cauley JA, et al
    Systemic markers of microvascular disease and bone mineral density in older adults : The cardiovascular health study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    May 2016
  157. ZHAO Y, Xue R, Shi N, Xue Y, et al
    Aggravation of spinal cord compromise following new osteoporotic vertebral compression fracture prevented by teriparatide in patients with surgical contraindications.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  158. SHIRAKI M, Ueda S, Sugimoto T, Kuroda T, et al
    Treatment responses with once-weekly teriparatide therapy for osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  159. KONAK HE, Kibar S, Ergin ES
    The effect of single-task and dual-task balance exercise programs on balance performance in adults with osteoporosis: a randomized controlled preliminary trial.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  160. BETHEL M, Weaver FM, Bailey L, Miskevics S, et al
    Risk factors for osteoporotic fractures in persons with spinal cord injuries and disorders.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  161. DENOVA-GUTIERREZ E, Clark P, Tucker KL, Munoz-Aguirre P, et al
    Dietary patterns are associated with bone mineral density in an urban Mexican adult population.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  162. WALKER MD, Saeed I, Lee JA, Zhang C, et al
    Effect of concomitant vitamin D deficiency or insufficiency on lumbar spine volumetric bone mineral density and trabecular bone score in primary hyperparathyroidism.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  163. IWANIEC UT, Philbrick KA, Wong CP, Gordon JL, et al
    Room temperature housing results in premature cancellous bone loss in growing female mice: implications for the mouse as a preclinical model for age-related bone loss.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  164. CHUNG SM, Hyun MH, Lee E, Seo HS, et al
    Novel effects of sarcopenic osteoarthritis on metabolic syndrome, insulin resistance, osteoporosis, and bone fracture: the national survey.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  165. HADJI P, Kyvernitakis I, Kann PH, Niedhart C, et al
    GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  166. HOPKINS RB, Burke N, Von Keyserlingk C, Leslie WD, et al
    The current economic burden of illness of osteoporosis in Canada.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  167. CUNNINGHAM TD, Martin BC, DeShields SC, Romero CC, et al
    The impact of osteoporotic fractures compared with other health conditions in older adults living in Virginia, United States.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  168. PENTON H, Hiligsmann M, Harrison M, Reginster JY, et al
    Potential cost-effectiveness for using patient decision aids to guide osteoporosis treatment.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  169. CHOW SK, Leung KS, Qin J, Guo A, et al
    Mechanical stimulation enhanced estrogen receptor expression and callus formation in diaphyseal long bone fracture healing in ovariectomy-induced osteoporotic rats.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  170. SOLTANI S, Hunter GR, Kazemi A, Shab-Bidar S, et al
    The effects of weight loss approaches on bone mineral density in adults: a systematic review and meta-analysis of randomized controlled trials.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  171. OLIVEIRA LC, Oliveira RG, Pires-Oliveira DA
    Effects of whole body vibration on bone mineral density in postmenopausal women: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  172. YANG TC, Duthie GG, Aucott LS, Macdonald HM, et al
    Vitamin E homologues alpha- and gamma-tocopherol are not associated with bone turnover markers or bone mineral density in peri-menopausal and post-menopausal women.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  173. MCCLUNG MR
    Cancel the denosumab holiday.
    Osteoporos Int. 2016;27:1677-82.
    PubMed     Text format    


  174. NIIMI R, Kono T, Nishihara A, Hasegawa M, et al
    Usefulness of daily teriparatide treatment in elderly patients over 80 years of age.
    Osteoporos Int. 2016;27:1869-74.
    PubMed     Text format     Abstract available


  175. PAUPITZ JA, Lima GL, Alvarenga JC, Oliveira RM, et al
    Bone impairment assessed by HR-pQCT in juvenile-onset systemic lupus erythematosus.
    Osteoporos Int. 2016;27:1839-48.
    PubMed     Text format     Abstract available


    April 2016
  176. METZGER CE, Baek K, Swift SN, De Souza MJ, et al
    Exercise during energy restriction mitigates bone loss but not alterations in estrogen status or metabolic hormones.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  177. WARD LM, Konji VN, Ma J
    The management of osteoporosis in children.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  178. ZHAO G, Liu X, Li F
    Balloon kyphoplasty versus percutaneous vertebroplasty for treatment of osteoporotic vertebral compression fractures (OVCFs).
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  179. BEAUDOIN C, Jean S, Bessette L, Ste-Marie LG, et al
    Denosumab compared to other treatments to prevent or treat osteoporosis in individuals at risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  180. SILVERMAN SL, Kupperman ES, Bukata SV
    Fracture healing: a consensus report from the International Osteoporosis Foundation Fracture Working Group.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  181. KIM YM, Kim SH, Kim S, Yoo JS, et al
    Variations in fat mass contribution to bone mineral density by gender, age, and body mass index: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008-2011.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  182. LESLIE WD, Majumdar SR, Lix LM, Josse RG, et al
    Direct comparison of FRAX and a simplified fracture risk assessment tool in routine clinical practice: a registry-based cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  183. WANG FS, Lian WS, Weng WT, Sun YC, et al
    Neuropeptide Y mediates glucocorticoid-induced osteoporosis and marrow adiposity in mice.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  184. YUN BH, Chon SJ, Choi YS, Cho S, et al
    The effect of prolonged breast-feeding on the development of postmenopausal osteoporosis in population with insufficient calcium intake and vitamin D level.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  185. HILIGSMANN M, Ronda G, van der Weijden T, Boonen A, et al
    The development of a personalized patient education tool for decision making for postmenopausal women with osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available



  186. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Committee of National Societies Abstracts.
    Osteoporos Int. 2016;27 Suppl 1:579-84.
    PubMed     Text format    



  187. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Non-sponsored Symposia Abstracts.
    Osteoporos Int. 2016;27 Suppl 1:555-77.
    PubMed     Text format    



  188. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Satellite Symposia Abstracts.
    Osteoporos Int. 2016;27 Suppl 1:549-53.
    PubMed     Text format    



  189. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Poster Abstracts.
    Osteoporos Int. 2016;27 Suppl 1:79-548.
    PubMed     Text format    



  190. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Meet-the-Expert Sessions.
    Osteoporos Int. 2016;27 Suppl 1:71-8.
    PubMed     Text format    



  191. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Educational Lecture Abstract.
    Osteoporos Int. 2016;27 Suppl 1:69.
    PubMed     Text format    



  192. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): ESCEO Symposia Abstracts.
    Osteoporos Int. 2016;27 Suppl 1:63-8.
    PubMed     Text format    



  193. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Oral Communication Abstracts.
    Osteoporos Int. 2016;27 Suppl 1:39-62.
    PubMed     Text format    



  194. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Plenary Lecture Abstracts.
    Osteoporos Int. 2016;27 Suppl 1:33-7.
    PubMed     Text format    



  195. WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
    Osteoporos Int. 2016;27 Suppl 1:1-32.
    PubMed     Text format    


  196. TSENTIDIS C, Gourgiotis D, Kossiva L, Doulgeraki A, et al
    Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
    Osteoporos Int. 2016;27:1631-43.
    PubMed     Text format     Abstract available


  197. HOFFMAN V, Xue F, Gardstein B, Skerry K, et al
    Assessment of off-label use of denosumab 60 mg injection during the early postmarketing period using health insurance claims data.
    Osteoporos Int. 2016;27:1653-8.
    PubMed     Text format     Abstract available


  198. JACQUOT J, Delion M, Gangloff S, Braux J, et al
    Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.
    Osteoporos Int. 2016;27:1401-12.
    PubMed     Text format     Abstract available


    March 2016
  199. DROSSELMEYER J, Rapp MA, Hadji P, Kostev K, et al
    Depression risk in female patients with osteoporosis in primary care practices in Germany.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  200. CAVALIER E, Bergmann P, Bruyere O, Delanaye P, et al
    The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  201. BHAVSAR NV, Trivedi SR, Dulani K, Brahmbhatt N, et al
    Clinical and radiographic evaluation of effect of risedronate 5 mg as an adjunct to treatment of chronic periodontitis in postmenopausal women (12-month study).
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  202. FROST SA, Nguyen TV
    Uncertain effects of calcium and vitamin D supplementation on fracture risk reduction.
    Osteoporos Int. 2016.
    PubMed     Text format    


  203. EVSTIGNEEVA L, Lesnyak O, Bultink IE, Lems WF, et al
    Effect of twelve-month physical exercise program on patients with osteoporotic vertebral fractures: a randomized, controlled trial.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  204. PERRY BA, Archer KR, Song Y, Ma Y, et al
    Erratum to: Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format    


  205. ROUX JP, Belghali S, Wegrzyn J, Rendu ES, et al
    Vertebral body morphology is associated with incident lumbar vertebral fracture in postmenopausal women. The OFELY study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  206. LOOKER AC, Sarafrazi Isfahani N, Fan B, Shepherd JA, et al
    Trabecular bone scores and lumbar spine bone mineral density of US adults: comparison of relationships with demographic and body size variables.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  207. WEAVER CM, Gordon CM, Janz KF, Kalkwarf HJ, et al
    Erratum to: The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations.
    Osteoporos Int. 2016.
    PubMed     Text format    


  208. BUCKINX F, Reginster JY, Cavalier E, Petermans J, et al
    Determinants of vitamin D supplementation prescription in nursing homes: a survey among general practitioners.
    Osteoporos Int. 2016;27:881-6.
    PubMed     Text format     Abstract available


  209. MOSTI MP, Flemmen G, Hoff J, Stunes AK, et al
    Impaired skeletal health and neuromuscular function among amphetamine users in clinical treatment.
    Osteoporos Int. 2016;27:1003-10.
    PubMed     Text format     Abstract available


  210. ZHANG Y, Wang L, Song Y, Zhao X, et al
    Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice.
    Osteoporos Int. 2016;27:1083-92.
    PubMed     Text format     Abstract available


  211. DAMIAN LO, Simon SP, Filipescu I, Bocsa C, et al
    Capillaroscopic findings in a case of Hajdu-Cheney syndrome.
    Osteoporos Int. 2016;27:1269-73.
    PubMed     Text format     Abstract available


  212. DUDLEY-JAVOROSKI S, Petrie MA, McHenry CL, Amelon RE, et al
    Bone architecture adaptations after spinal cord injury: impact of long-term vibration of a constrained lower limb.
    Osteoporos Int. 2016;27:1149-60.
    PubMed     Text format     Abstract available


    February 2016
  213. PERRY BA, Archer KR, Song Y, Ma Y, et al
    Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  214. HOPKINS SJ, Toms AD, Brown M, Welsman JR, et al
    A study investigating short- and medium-term effects on function, bone mineral density and lean tissue mass post-total knee replacement in a Caucasian female post-menopausal population: implications for hip fracture risk.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  215. LINDSAY R, Krege JH, Marin F, Jin L, et al
    Teriparatide for osteoporosis: importance of the full course.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  216. EL-HAJ M, Gurt I, Cohen-Kfir E, Dixit V, et al
    Reduced Sirtuin1 expression at the femoral neck in women who sustained an osteoporotic hip fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  217. ROSSINI M, Zanotti R, Orsolini G, Tripi G, et al
    Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  218. DELESKOG L, Laursen NO, Nielsen BR, Schwarz P, et al
    Vertebral fracture assessment by DXA is inferior to X-ray in clinical severe osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  219. LIM Y, Chun S, Lee JH, Baek KH, et al
    Association of bone mineral density and diabetic retinopathy in diabetic subjects: the 2008-2011 Korea National Health and Nutrition Examination Survey.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  220. RIZZOLI R, Benhamou CL, Halse J, Miller PD, et al
    Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  221. CHEN CH, Lin CL, Kao CH
    Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  222. WEAVER CM, Gordon CM, Janz KF, Kalkwarf HJ, et al
    The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  223. NORIEGA DC, Ramajo RH, Lite IS, Toribio B, et al
    Safety and clinical performance of kyphoplasty and SpineJack procedures in the treatment of osteoporotic vertebral compression fractures: a pilot, monocentric, investigator-initiated study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  224. BRUNETTI G, Papadia F, Tummolo A, Fischetto R, et al
    Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-alpha.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  225. LLOYD JT, Alley DE, Hochberg MC, Waldstein SR, et al
    Changes in bone mineral density over time by body mass index in the health ABC study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  226. GUARINO M, Loperto I, Camera S, Cossiga V, et al
    Osteoporosis across chronic liver disease.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  227. LAM FM, Bui M, Yang FZ, Pang MY, et al
    Chronic effects of stroke on hip bone density and tibial morphology: a longitudinal study.
    Osteoporos Int. 2016;27:591-603.
    PubMed     Text format     Abstract available


  228. VIAENE L, Behets GJ, Heye S, Claes K, et al
    Inflammation and the bone-vascular axis in end-stage renal disease.
    Osteoporos Int. 2016;27:489-97.
    PubMed     Text format     Abstract available


  229. HWANGBO Y, Kim JH, Kim SW, Park YJ, et al
    High-normal free thyroxine levels are associated with low trabecular bone scores in euthyroid postmenopausal women.
    Osteoporos Int. 2016;27:457-62.
    PubMed     Text format     Abstract available


  230. KAWALILAK CE, Johnston JD, Cooper DM, Olszynski WP, et al
    Role of endocortical contouring methods on precision of HR-pQCT-derived cortical micro-architecture in postmenopausal women and young adults.
    Osteoporos Int. 2016;27:789-96.
    PubMed     Text format     Abstract available


  231. KHEIR V, Munier FL, Aubry-Rozier B, Schorderet DF, et al
    Potential blindness in children of patients with hereditary bone disease.
    Osteoporos Int. 2016;27:841-4.
    PubMed     Text format     Abstract available


  232. TAN J, Fu X, Sun CG, Liu C, et al
    A single CT-guided percutaneous intraosseous injection of thermosensitive simvastatin/poloxamer 407 hydrogel enhances vertebral bone formation in ovariectomized minipigs.
    Osteoporos Int. 2016;27:757-67.
    PubMed     Text format     Abstract available


    January 2016
  233. SI L, Winzenberg TM, Chen M, Jiang Q, et al
    Screening for osteoporosis in Chinese post-menopausal women: a health economic modelling study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  234. DOU C, Chen Y, Ding N, Li N, et al
    Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  235. PEDERSEN AB, Baggesen LM, Ehrenstein V, Pedersen L, et al
    Perceived stress and risk of any osteoporotic fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  236. MUSUMECI M, Palermo A, D'Onofrio L, Vadala G, et al
    Erratum to: Serum chitotriosidase in postmenopausal women with severe osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format    


  237. AMICHE MA, Albaum JM, Tadrous M, Pechlivanoglou P, et al
    Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  238. KATZMAN WB, Vittinghoff E, Kado DM, Lane NE, et al
    Thoracic kyphosis and rate of incident vertebral fractures: the Fracture Intervention Trial.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  239. LEE JH, Lee YK, Oh SH, Ahn J, et al
    A systematic review of diagnostic accuracy of vertebral fracture assessment (VFA) in postmenopausal women and elderly men.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  240. DREW S, Judge A, Cooper C, Javaid MK, et al
    Secondary prevention of fractures after hip fracture: a qualitative study of effective service delivery.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  241. WANG X, Yan S, Liu C, Xu Y, et al
    Fracture risk and bone mineral density levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  242. ZHANG ZQ, Cao WT, Liu J, Cao Y, et al
    Greater serum carotenoid concentration associated with higher bone mineral density in Chinese adults.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  243. ZHENG Y, Wang C, Zhang H, Shao C, et al
    Polymorphisms in Wnt signaling pathway genes are associated with peak bone mineral density, lean mass, and fat mass in Chinese male nuclear families.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  244. WANG J, Yao M, Xu JH, Shu B, et al
    Bisphosphonates for prevention of osteopenia in kidney-transplant recipients: a systematic review of randomized controlled trials.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  245. LI M, Lv F, Zhang Z, Deng W, et al
    Establishment of a normal reference value of parathyroid hormone in a large healthy Chinese population and evaluation of its relation to bone turnover and bone mineral density.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  246. LESLIE WD, Schousboe JT, Lix LM
    Towards better use of the net reclassification improvement (NRI) index.
    Osteoporos Int. 2016;27:411-2.
    PubMed     Text format    


  247. NAYLOR KE, Jacques RM, Paggiosi M, Gossiel F, et al
    Bone turnover markers: response to comments by Seeman and Nguyen.
    Osteoporos Int. 2016;27:37.
    PubMed     Text format    


  248. LEIB ES, Winzenrieth R
    Bone status in glucocorticoid-treated men and women.
    Osteoporos Int. 2016;27:39-48.
    PubMed     Text format     Abstract available


  249. MATUTE-LLORENTE A, Gonzalez-Aguero A, Gomez-Cabello A, Tous-Fajardo J, et al
    Effect of whole-body vibration training on bone mass in adolescents with and without Down syndrome: a randomized controlled trial.
    Osteoporos Int. 2016;27:181-91.
    PubMed     Text format     Abstract available


  250. EASTELL R, Dijk DJ, Small M, Greenwood A, et al
    Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial.
    Osteoporos Int. 2016;27:309-18.
    PubMed     Text format     Abstract available


    December 2015
  251. AMICHE MA, Albaum JM, Tadrous M, Pechlivanoglou P, et al
    Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  252. POPP AW, Zysset PK, Lippuner K
    Rebound-associated vertebral fractures after discontinuation of denosumab-from clinic and biomechanics.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  253. CHEN JS, Hill CL, Lester S, Ruediger CD, et al
    Supplementation with omega-3 fish oil has no effect on bone mineral density in adults with knee osteoarthritis: a 2-year randomized controlled trial.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  254. COLOMA PM, de Ridder M, Bezemer I, Herings RM, et al
    Risk of cardiac valvulopathy with use of bisphosphonates: a population-based, multi-country case-control study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  255. ANASTASILAKIS AD, Makras P
    Multiple clinical vertebral fractures following denosumab discontinuation.
    Osteoporos Int. 2015.
    PubMed     Text format    


  256. SILVERMAN SL, Adachi JD, Dennison E
    Bisphosphonate drug holidays: we reap what we sow.
    Osteoporos Int. 2015.
    PubMed     Text format    


  257. SVENSSON HK, Olofsson EH, Karlsson J, Hansson T, et al
    A painful, never ending story: older women's experiences of living with an osteoporotic vertebral compression fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  258. KLASSEN KM, Kimlin MG, Fairley CK, Emery S, et al
    Associations between vitamin D metabolites, antiretroviral therapy and bone mineral density in people with HIV.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  259. BETHEL M, Buzkova P, Fink HA, Robbins JA, et al
    Soluble CD14 and fracture risk.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  260. FREITAS PM, Garcia Rosa ML, Gomes AM, Wahrlich V, et al
    Central and peripheral fat body mass have a protective effect on osteopenia or osteoporosis in adults and elderly?
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  261. OIKONOMIDOU PR, Casu C, Yang Z, Crielaard B, et al
    Polycythemia is associated with bone loss and reduced osteoblast activity in mice.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  262. NAKAYAMA A, Major G, Holliday E, Attia J, et al
    Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  263. XU LH, Adams-Huet B, Poindexter JR, Maalouf NM, et al
    Determinants of change in bone mineral density and fracture risk during bisphosphonate holiday.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  264. MODI A, Sen S, Adachi JD, Adami S, et al
    Gastrointestinal symptoms and association with medication use patterns, adherence, treatment satisfaction, quality of life, and resource use in osteoporosis: baseline results of the MUSIC-OS study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  265. BOURS S, de Vries F, van den Bergh JP, Lalmohamed A, et al
    Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  266. RUDANG R, Zoulakis M, Sundh D, Brisby H, et al
    Bone material strength is associated with areal BMD but not with prevalent fractures in older women.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  267. PENONI DC, Torres SR, Farias ML, Fernandes TM, et al
    Association of osteoporosis and bone medication with the periodontal condition in elderly women.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available



  268. IOF Regionals - 3rd Middle East & Africa Osteoporosis Meeting : Poster Presentation Abstracts.
    Osteoporos Int. 2015;26 Suppl 2:439-86.
    PubMed     Text format    



  269. IOF Regionals - 3rd Middle East & Africa Osteoporosis Meeting : Oral Communication Abstracts.
    Osteoporos Int. 2015;26 Suppl 2:427-37.
    PubMed     Text format    



  270. IOF Regionals - 3rd Middle East & Africa Osteoporosis Meeting : Plenary Lecture Abstracts.
    Osteoporos Int. 2015;26 Suppl 2:421-5.
    PubMed     Text format    


    November 2015
  271. ZHOU B, Huang Y, Li H, Sun W, et al
    Proton pump inhibitors and fracture risk: response to comments.
    Osteoporos Int. 2015.
    PubMed     Text format    


  272. KUIPERS AL, Miljkovic I, Evans R, Bunker CH, et al
    Optimal serum cholesterol concentrations are associated with accelerated bone loss in African ancestry men.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  273. SENAY A, Delisle J, Raynauld JP, Morin SN, et al
    Agreement between physicians' and nurses' clinical decisions for the management of the fracture liaison service (4iFLS): the Lucky Bone program.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  274. BROZEK W, Reichardt B, Zwerina J, Dimai HP, et al
    Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  275. MARCINIAK C, Gabet J, Lee J, Ma M, et al
    Osteoporosis in adults with cerebral palsy: feasibility of DXA screening and risk factors for low bone density.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  276. MA C, Shuai B, Shen L, Yang YP, et al
    Serum carcinoembryonic antigen-related cell adhesion molecule 1 level in postmenopausal women: correlation with beta-catenin and bone mineral density.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  277. AVILA ML, Pullenayegum E, Williams S, Shammas A, et al
    Timing of low bone mineral density and predictors of bone mineral density trajectory in children on long-term warfarin: a longitudinal study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  278. MCCLOSKEY E
    A BMD threshold for treatment efficacy in osteoporosis? A need to consider the whole evidence base.
    Osteoporos Int. 2015.
    PubMed     Text format    


  279. UZOIGWE CE
    The real enemy is fragility fracture, not osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format    


  280. CLARK EM, Gooberman-Hill R, Peters TJ
    Using self-reports of pain and other variables to distinguish between older women with back pain due to vertebral fractures and those with back pain due to degenerative changes.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  281. LI Y, Zhou J, Wu Y, Lu T, et al
    Association of osteoporosis with genetic variants of circadian genes in Chinese geriatrics.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  282. KARJALAINEN JP, Riekkinen O, Toyras J, Jurvelin JS, et al
    New method for point-of-care osteoporosis screening and diagnostics.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  283. COSMAN F, Gilchrist N, McClung M, Foldes J, et al
    A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  284. CHEN F, Dai Z, Kang Y, Lv G, et al
    Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  285. FARSINEJAD-MARJ M, Saneei P, Esmaillzadeh A
    Dietary magnesium intake, bone mineral density and risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  286. MURRAY JC, Audet MC, Bedard M, Michou L, et al
    Bilateral distal fibula fractures in a woman on long-term bisphosphonate therapy.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  287. SUGIYAMA T, Torio T, Miyajima T, Kim YT, et al
    Calcium, proton pump inhibitors, and fracture risk.
    Osteoporos Int. 2015.
    PubMed     Text format    


  288. RUD B, Vestergaard A, Hyldstrup L
    Accuracy of densitometric vertebral fracture assessment when performed by DXA technicians-a cross-sectional, multiobserver study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  289. BEALL DP, Feldman RG, Gordon ML, Gruber BL, et al
    Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  290. SUMIDA K, Ubara Y, Hoshino J, Mise K, et al
    Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: a prospective study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    October 2015
  291. JACOB L, Dreher M, Kostev K, Hadji P, et al
    Increased treatment persistence and its determinants in women with osteoporosis with prior fracture compared to those without fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  292. SATO H, Kondo N, Wada Y, Nakatsue T, et al
    The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  293. WEAVER CM, Alexander DD, Boushey CJ, Dawson-Hughes B, et al
    Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  294. DARUWALLA ZJ, Huq SS, Wong KL, Nee PY, et al
    Hip fractures, preceding distal radius fractures and screening for osteoporosis: should we be screening earlier? A minimum 10-year retrospective cohort study at a single centre.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  295. SANTI D, Madeo B, Carli F, Zona S, et al
    Serum total estradiol, but not testosterone is associated with reduced bone mineral density (BMD) in HIV-infected men: a cross-sectional, observational study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  296. AUBRY-ROZIER B, Gonzalez-Rodriguez E, Stoll D, Lamy O, et al
    Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  297. SELGA J, Nunez JH, Minguell J, Lalanza M, et al
    Simultaneous bilateral atypical femoral fracture in a patient receiving denosumab: case report and literature review.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  298. HOLM JP, Amar AO, Hyldstrup L, Jensen JE, et al
    Hyponatremia, a risk factor for osteoporosis and fractures in women.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  299. SUGIYAMA T, Kim YT, Oda H
    Both falling and bone fragility should be targeted to prevent hip fracture in older adults.
    Osteoporos Int. 2015.
    PubMed     Text format    


  300. EARLY C, Stuckey L, Tischer S
    Osteoporosis in the adult solid organ transplant population: underlying mechanisms and available treatment options.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  301. EBINA K, Noguchi T, Hirao M, Hashimoto J, et al
    Effects of switching weekly alendronate or risedronate to monthly minodronate in patients with rheumatoid arthritis: a 12-month prospective study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  302. WEN Y, Guo X, Hao J, Xiao X, et al
    Integrative analysis of genome-wide association studies and gene expression profiles identified candidate genes for osteoporosis in Kashin-Beck disease patients.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  303. FINK HA, Litwack-Harrison S, Taylor BC, Bauer DC, et al
    Clinical utility of routine laboratory testing to identify possible secondary causes in older men with osteoporosis: the Osteoporotic Fractures in Men (MrOS) Study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  304. RAMCHAND SK, Chiang CY, Zebaze RM, Seeman E, et al
    Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  305. SOLOMON DH, Ruppert K, Zhao Z, Lian YJ, et al
    Bone mineral density changes among women initiating blood pressure lowering drugs: a SWAN cohort study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  306. WANG Q, Huang Q, Zeng Y, Liang JJ, et al
    Parity and osteoporotic fracture risk in postmenopausal women: a dose-response meta-analysis of prospective studies.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  307. EIKEN P, Vestergaard P
    Treatment of osteoporosis after alendronate or risedronate.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  308. DONNER DG, Elliott GE, Beck BR, Forwood MR, et al
    The effects of visceral obesity and androgens on bone: trenbolone protects against loss of femoral bone mineral density and structural strength in viscerally obese and testosterone-deficient male rats.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  309. HOLLOWAY KL, Henry MJ, Brennan-Olsen SL, Bucki-Smith G, et al
    Non-hip and non-vertebral fractures: the neglected fracture sites.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    September 2015
  310. GIFRE L, Vidal J, Carrasco JL, Muxi A, et al
    Denosumab increases sublesional bone mass in osteoporotic individuals with recent spinal cord injury.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  311. HEGDE V, Jo JE, Andreopoulou P, Lane JM, et al
    Effect of osteoporosis medications on fracture healing.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  312. LEE SJ, Binkley N, Lubner MG, Bruce RJ, et al
    Opportunistic screening for osteoporosis using the sagittal reconstruction from routine abdominal CT for combined assessment of vertebral fractures and density.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  313. LUO D, Ren H, Li T, Lian K, et al
    Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  314. ETHGEN O, Hiligsmann M, Burlet N, Reginster JY, et al
    Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  315. ALARCON T, Gonzalez-Montalvo JI, Martin-Vega A, Gotor P, et al
    Improving persistence and adherence to osteoporosis treatment: a challenge to solve.
    Osteoporos Int. 2015.
    PubMed     Text format    


  316. YAO W, Dai W, Jiang L, Lay EY, et al
    Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  317. ZHANG ZL, Liao EY, Xia WB, Lin H, et al
    Erratum to: Alendronate sodium/vitamin D combination tablet versus calcitriol for osteoporosis in Chinese postmenopausal women: a 6-month, randomized, open-label, active-comparator-controlled study with a 6-month extension.
    Osteoporos Int. 2015.
    PubMed     Text format    


  318. HWANG IR, Choi YK, Lee WK, Kim JG, et al
    Association between prolonged breastfeeding and bone mineral density and osteoporosis in postmenopausal women: KNHANES 2010-2011.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  319. YUAN HF, Guo CA, Yan ZQ
    The use of bisphosphonate in the treatment of osteonecrosis of the femoral head: a meta-analysis of randomized control trials.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  320. LUO Y
    A biomechanical sorting of clinical risk factors affecting osteoporotic hip fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  321. BONE HG, Dempster DW, Eisman JA, Greenspan SL, et al
    Erratum to: Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial.
    Osteoporos Int. 2015.
    PubMed     Text format    


  322. JEMIELITA TO, Leonard MB, Baker J, Sayed S, et al
    Association of 25-hydroxyvitamin D with areal and volumetric measures of bone mineral density and parathyroid hormone: impact of vitamin D-binding protein and its assays.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  323. FRITZ J, Coster ME, Nilsson JA, Rosengren BE, et al
    The associations of physical activity with fracture risk-a 7-year prospective controlled intervention study in 3534 children.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  324. SHIN J, Sung J, Lee K, Song YM, et al
    Genetic influence on the association between bone mineral density and testosterone in Korean men.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  325. CARBONE S, Papalia M
    The amount of impaction and loss of reduction in osteoporotic proximal humeral fractures after surgical fixation.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  326. JURIMAE J, Tillmann V, Cicchella A, Stefanelli C, et al
    Increased sclerostin and preadipocyte factor-1 levels in prepubertal rhythmic gymnasts: associations with bone mineral density, body composition, and adipocytokine values.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  327. KRISHNAMOORTHY D, Frechette DM, Adler BJ, Green DE, et al
    Marrow adipogenesis and bone loss that parallels estrogen deficiency is slowed by low-intensity mechanical signals.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    August 2015
  328. THORIN MH, Wihlborg A, Akesson K, Gerdhem P, et al
    Smoking, smoking cessation, and fracture risk in elderly women followed for 10 years.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  329. EDWARDS BJ, Gradishar WJ, Smith ME, Pacheco JA, et al
    Elevated incidence of fractures in women with invasive breast cancer.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  330. MOON RJ, Lim A, Farmer M, Segaran A, et al
    Validity of parental recall of children's fracture: implications for investigation of childhood osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  331. CLARK EM, Gould VC, Tobias JH, Horne R, et al
    Natural history, reasons for, and impact of low/non-adherence to medications for osteoporosis in a cohort of community-dwelling older women already established on medication: a 2-year follow-up study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  332. HOLZMUELLER CG, Karp S, Zeldow D, Lee DB, et al
    Development of a cloud-based application for the Fracture Liaison Service model of care.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  333. KARLSSON L, Lundkvist J, Psachoulia E, Intorcia M, et al
    Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  334. YONG JH, Masucci L, Hoch JS, Sujic R, et al
    Cost-effectiveness of a fracture liaison service-a real-world evaluation after 6 years of service provision.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  335. FECHTENBAUM J, Etcheto A, Kolta S, Feydy A, et al
    Sagittal balance of the spine in patients with osteoporotic vertebral fractures.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  336. HU S, Liu CC, Chen G, Willett T, et al
    In vivo effects of two novel ALN-EP4a conjugate drugs on bone in the ovariectomized rat model for reversing postmenopausal bone loss.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  337. BARZILAY JI, Buzkova P, Kizer JR, Djousse L, et al
    Fibrosis markers, hip fracture risk, and bone density in older adults.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  338. SACHELARIE L, Farcas DM, Dartu L, Vasiliu M, et al
    Comparative study of diseases of the stomatognathic system and specific parameters of osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  339. DUMIC M, Putarek NR, Kusec V, Barisic N, et al
    Low bone mineral density for age/osteoporosis in triple A syndrome-an overlooked symptom of unexplained etiology.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  340. IWATA T, Ito H, Furu M, Hashimoto M, et al
    Periarticular osteoporosis of the forearm correlated with joint destruction and functional impairment in patients with rheumatoid arthritis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  341. MUSUMECI M, Palermo A, D'Onofrio L, Vadala G, et al
    Serum chitotriosidase in postmenopausal women with severe osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  342. HE H, Liu Y, Tian Q, Papasian CJ, et al
    Relationship of sarcopenia and body composition with osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  343. CHANG CY, Tang CH, Chen KC, Huang KC, et al
    The mortality and direct medical costs of osteoporotic fractures among postmenopausal women in Taiwan.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  344. LESLIE WD, Brennan-Olsen SL, Morin SN, Lix LM, et al
    Fracture prediction from repeat BMD measurements in clinical practice.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    July 2015
  345. YAN Z, Huang H, Li J, Wang J, et al
    Relationship between subclinical thyroid dysfunction and the risk of fracture: a meta-analysis of prospective cohort studies.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  346. LIU Z, Weaver J, de Papp A, Li Z, et al
    Disparities in osteoporosis treatments.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  347. HA KY, Park KS, Kim SI, Kim YH, et al
    Does bisphosphonate-based anti-osteoporosis medication affect osteoporotic spinal fracture healing?
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  348. PAPAPOULOS S, Lippuner K, Roux C, Lin CJ, et al
    The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  349. GILLETTE C, Howerton DM, Williams BD, Mahmood MA, et al
    Medication persistence in older women with osteoporosis: a pilot study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  350. ZHUKOUSKAYA VV, Eller-Vainicher C, Gaudio A, Privitera F, et al
    Erratum to: The utility of lumbar spine trabecular bone score and femoral neck bone mineral density for identifying asymptomatic vertebral fractures in well-compensated type 2 diabetic patients.
    Osteoporos Int. 2015.
    PubMed     Text format    


  351. LING Y, Gao X, Lin H, Ma H, et al
    A common polymorphism rs1800247 in osteocalcin gene was associated with serum osteocalcin levels, bone mineral density, and fracture: the Shanghai Changfeng Study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  352. SILVERMAN SL, Wang A, Cheng L, Yang Y, et al
    Comorbidity indices for clinical trials: adaptation of two existing indices for use with the FREEDOM trial in women with postmenopausal osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  353. NOORAFSHAN A, Dabbaghmanesh MH, Tanideh N, Koohpeyma F, et al
    Stereological study of the effect of black olive hydroalcoholic extract on osteoporosis in vertebra and tibia in ovariectomized rats.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  354. PICKHARDT PJ, Lauder T, Pooler BD, Munoz Del Rio A, et al
    Effect of IV contrast on lumbar trabecular attenuation at routine abdominal CT: correlation with DXA and implications for opportunistic osteoporosis screening.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  355. ALBAUM JM, Levesque LE, Gershon AS, Liu G, et al
    Glucocorticoid-induced osteoporosis management among seniors, by year, sex, and indication, 1996-2012.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  356. ZHUKOUSKAYA VV, Vainicher CE, Gaudio A, Privitera F, et al
    The utility of lumbar spine trabecular bone score and femoral neck bone mineral density for identifying asymptomatic vertebral fractures in well-compensated type 2 diabetic patients.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  357. COMPSTON J
    Overdiagnosis of osteoporosis: fact or fallacy?
    Osteoporos Int. 2015.
    PubMed     Text format    


  358. LIU W, Wang T, Yang C, Darvell BW, et al
    Alkaline biodegradable implants for osteoporotic bone defects-importance of microenvironment pH.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  359. OLMOS JM, Hernandez JL, Garcia-Velasco P, Martinez J, et al
    Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  360. WANG CY, Fu SH, Wang CL, Chen PJ, et al
    Serotonergic antidepressant use and the risk of fracture: a population-based nested case-control study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    June 2015
  361. AMOUZOUGAN A, Deygat A, Trombert B, Constant E, et al
    Spectacular improvement in vitamin D status in elderly osteoporotic women: 8-year analysis of an osteoporotic population treated in a dedicated fracture liaison service.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  362. TIAN FM, Yang K, Wang WY, Luo Y, et al
    Calcitonin suppresses intervertebral disk degeneration and preserves lumbar vertebral bone mineral density and bone strength in ovariectomized rats.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  363. YOSHIGA D, Sasaguri M, Matsuo K, Kokuryou S, et al
    Erratum to: Intraoperative detection of viable bone with fluorescence imaging using Visually Enhanced Lesion Scope in patients with bisphosphonate-related osteonecrosis of the jaw: clinical and pathological evaluation.
    Osteoporos Int. 2015.
    PubMed     Text format    


  364. NIIMI R, Kono T, Nishihara A, Hasegawa M, et al
    Erratum to: Analysis of daily teriparatide treatment for osteoporosis in men.
    Osteoporos Int. 2015.
    PubMed     Text format    


  365. HARVEY NC, Kanis JA, Oden A, Burge RT, et al
    FRAX and the effect of teriparatide on vertebral and non-vertebral fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  366. HERNANDEZ I, Pinera A
    Incidence of fracture events with teriparatide: role of study design.
    Osteoporos Int. 2015.
    PubMed     Text format    


  367. HARVEY NC, Kanis JA, Oden A, Nakamura T, et al
    Efficacy of weekly teriparatide does not vary by baseline fracture probability calculated using FRAX.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  368. D'AMELIO P, Sassi F, Buondonno I, Fornelli G, et al
    Treatment with intermittent PTH increases Wnt10b production by T cells in osteoporotic patients.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  369. FERRARI S, Adachi JD, Lippuner K, Zapalowski C, et al
    Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  370. ZHANG C, Ma J, Chen G, Fu D, et al
    Evaluation of common variants in CNR2 gene for bone mineral density and osteoporosis susceptibility in postmenopausal women of Han Chinese.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  371. BRIOT K, Fechtenbaum J, Etcheto A, Kolta S, et al
    Diagnosis of vertebral fractures using a low-dose biplanar imaging system.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  372. GUO Z, Yang J, Zheng Y, Wang Y, et al
    Thoracolumbar fascia injury associated with residual back pain after percutaneous vertebroplasty: a compelling study.
    Osteoporos Int. 2015.
    PubMed     Text format    


  373. NARANJO A, Ojeda-Bruno S, Bilbao-Cantarero A, Quevedo-Abeledo JC, et al
    Two-year adherence to treatment and associated factors in a fracture liaison service in Spain.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  374. YAN Y, Zou T, Xu R
    Reply to "Thoracolumbar fascia injury associated with residual back pain after percutaneous vertebroplasty: a compelling study".
    Osteoporos Int. 2015.
    PubMed     Text format    


  375. YOSHIGA D, Sasaguri M, Matsuo K, Kokuryou S, et al
    Intraoperative detection of viable bone with fluorescence imaging using Visually Enhanced Lesion Scope in patients with bisphosphonate-related osteonecrosis of the jaw: clinical and pathological evaluation.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    May 2015
  376. HADJI P, Papaioannou N, Gielen E, Feudjo Tepie M, et al
    Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  377. NAKAMURA T, Ito M, Hashimoto J, Shinomiya K, et al
    Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  378. CROCKETT K, Arnold CM, Farthing JP, Chilibeck PD, et al
    Bone strength and muscle properties in postmenopausal women with and without a recent distal radius fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  379. SANGTARASH F, Manshadi FD, Sadeghi A
    The relationship of thoracic kyphosis to gait performance and quality of life in women with osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  380. MATUTE-LLORENTE A, Gonzalez-Aguero A, Gomez-Cabello A, Olmedillas H, et al
    Effect of whole body vibration training on bone mineral density and bone quality in adolescents with Down syndrome: a randomized controlled trial.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  381. NAYLOR KE, Jacques RM, Paggiosi M, Gossiel F, et al
    Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  382. WU CT, Yang YH, Chen PC, Chen MF, et al
    Androgen deprivation increases the risk of fracture in prostate cancer patients: a population-based study in Chinese patients.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  383. TIAN Y, Shen L, Wu J, Xu G, et al
    Sleep duration and timing in relation to osteoporosis in an elderly Chinese population: a cross-sectional analysis in the Dongfeng-Tongji cohort study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  384. MARQUES A, Lourenco O, da Silva JA
    The burden of osteoporotic hip fractures in Portugal: costs, health related quality of life and mortality.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  385. COSMAN F, de Beur SJ, LeBoff MS, Lewiecki EM, et al
    Erratum to: Clinician's guide to prevention and treatment of osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format    


  386. TSUKUTANI Y, Hagino H, Ito Y, Nagashima H, et al
    Epidemiology of fragility fractures in Sakaiminato, Japan: incidence, secular trends, and prognosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  387. WANG O, Hu Y, Gong S, Xue Q, et al
    A survey of outcomes and management of patients post fragility fractures in China.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  388. KEMMLER W, Bebenek M, Kohl M, von Stengel S, et al
    Exercise and fractures in postmenopausal women. Final results of the controlled Erlangen Fitness and Osteoporosis Prevention Study (EFOPS).
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  389. MIYAKOSHI N, Hongo M, Kobayashi T, Abe T, et al
    Improvement of spinal alignment and quality of life after corrective surgery for spinal kyphosis in patients with osteoporosis: a comparative study with non-operated patients.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  390. KLOP C, Gibson-Smith D, Elders PJ, Welsing PM, et al
    Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  391. XIN M, Yang Y, Zhang D, Wang J, et al
    Attenuation of hind-limb suspension-induced bone loss by curcumin is associated with reduced oxidative stress and increased vitamin D receptor expression.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  392. FERLIN A, Selice R, Di Mambro A, Ghezzi M, et al
    Role of vitamin D levels and vitamin D supplementation on bone mineral density in Klinefelter syndrome.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  393. YOUN JC, Lee SJ, Lee HS, Oh J, et al
    Exercise capacity independently predicts bone mineral density and proximal femoral geometry in patients with acute decompensated heart failure.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  394. HOOVER KB, Miller CG, Galante NC, Langman CB, et al
    A double-blind, randomized, Phase III, multicenter study in 358 pediatric subjects receiving isotretinoin therapy demonstrates no effect on pediatric bone mineral density.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  395. CIZMIC AD, Heilmann RM, Milchak JL, Riggs CS, et al
    Impact of interactive voice response technology on primary adherence to bisphosphonate therapy: a randomized controlled trial.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  396. SCILLITANI A, Mazziotti G, Di Somma C, Moretti S, et al
    Cortisol and the muscle-bone axis: response to comments by Molfino et al.
    Osteoporos Int. 2015;26:1661-2.
    PubMed     Text format    


  397. BURDEN AM, Tadrous M, Calzavara A, Cadarette SM, et al
    Uptake and characteristics of zoledronic acid and denosumab patients and physicians in Ontario, Canada: impact of drug formulary access.
    Osteoporos Int. 2015;26:1525-33.
    PubMed     Text format     Abstract available


  398. BINKLEY N, Lappe J, Singh RJ, Khosla S, et al
    Can vitamin D metabolite measurements facilitate a "treat-to-target" paradigm to guide vitamin D supplementation?
    Osteoporos Int. 2015;26:1655-60.
    PubMed     Text format     Abstract available


    April 2015
  399. KREGE JH, Burge RT, Marin F
    Teriparatide fracture effectiveness in the real world.
    Osteoporos Int. 2015.
    PubMed     Text format    


  400. AHMED LA, Shigdel R, Joakimsen RM, Eldevik OP, et al
    Measurement of cortical porosity of the proximal femur improves identification of women with nonvertebral fragility fractures.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  401. VAN DEN BERG P, Schweitzer DH, van Haard PM, van den Bergh JP, et al
    Meeting international standards of secondary fracture prevention: a survey on Fracture Liaison Services in the Netherlands.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  402. WIHLBORG A, Englund M, Akesson K, Gerdhem P, et al
    Fracture predictive ability of physical performance tests and history of falls in elderly women: a 10-year prospective study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  403. EBINA K, Hashimoto J, Shi K, Kashii M, et al
    Undercarboxylated osteocalcin may be an attractive marker of teriparatide treatment in RA patients: response to Mokuda.
    Osteoporos Int. 2015;26:1445.
    PubMed     Text format    


  404. MOKUDA S
    Undercarboxylated osteocalcin may be an attractive marker of teriparatide treatment in rheumatoid arthritis patients.
    Osteoporos Int. 2015;26:1443.
    PubMed     Text format    


  405. MURAI IH, Roschel H, Pabis LV, Takayama L, et al
    Exercise training, creatine supplementation, and bone health in ovariectomized rats.
    Osteoporos Int. 2015;26:1395-404.
    PubMed     Text format     Abstract available


  406. CESAREO R, Di Stasio E, Vescini F, Campagna G, et al
    Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism.
    Osteoporos Int. 2015;26:1295-302.
    PubMed     Text format     Abstract available


    March 2015
  407. ITO K, Leslie WD
    Cost-effectiveness of fracture prevention in rural women with limited access to dual-energy X-ray absorptiometry.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  408. BABA T, Hagino H, Nonomiya H, Ikuta T, et al
    Inadequate management for secondary fracture prevention in patients with distal radius fracture by trauma surgeons.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  409. DAMJI AN, Bies K, Alibhai SM, Jones JM, et al
    Bone health management in men undergoing ADT: examining enablers and barriers to care.
    Osteoporos Int. 2015;26:951-9.
    PubMed     Text format     Abstract available


  410. BORON D, Kaminski A, Kotrych D, Bogacz A, et al
    Polymorphism of vitamin D3 receptor and its relation to mineral bone density in perimenopausal women.
    Osteoporos Int. 2015;26:1045-52.
    PubMed     Text format     Abstract available


  411. KRAUSE M, Keller J, Beil B, van Driel I, et al
    Calcium gluconate supplementation is effective to balance calcium homeostasis in patients with gastrectomy.
    Osteoporos Int. 2015;26:987-95.
    PubMed     Text format     Abstract available


    February 2015
  412. MCCLOSKEY EV, Kanis JA, Oden A, Harvey NC, et al
    Predictive ability of heel quantitative ultrasound for incident fractures: an individual-level meta-analysis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  413. RASCH LA, van Tuyl LH, de van der Schueren MA, Bultink IE, et al
    Estimation of dietary calcium intake.
    Osteoporos Int. 2015;26:835-6.
    PubMed     Text format    


  414. MACDONALD HM, Black AJ
    Validation of a short questionnaire for estimating dietary calcium intakes.
    Osteoporos Int. 2015;26:837.
    PubMed     Text format    


  415. LAI CC, Chen WS, Chang DM, Tsao YP, et al
    Increased serum fibroblast growth factor-23 and decreased bone turnover in patients with systemic lupus erythematosus under treatment with cyclosporine and steroid but not steroid only.
    Osteoporos Int. 2015;26:601-10.
    PubMed     Text format     Abstract available


    January 2015
  416. LOOKER AC
    Dysmobility syndrome and mortality risk in US men and women age 50 years and older.
    Osteoporos Int. 2015;26:93-102.
    PubMed     Text format     Abstract available


  417. KALLURU R, Ames R, Mason B, Bolland MJ, et al
    Bone density in healthy men after cessation of calcium supplements: 20-month follow-up of a randomized controlled trial.
    Osteoporos Int. 2015;26:173-8.
    PubMed     Text format     Abstract available


  418. YOSHIMURA N, Muraki S, Oka H, Nakamura K, et al
    Serum levels of 25-hydroxyvitamin D and the occurrence of musculoskeletal diseases: a 3-year follow-up to the road study.
    Osteoporos Int. 2015;26:151-61.
    PubMed     Text format     Abstract available


  419. RIZZOLI R, Sigaud A, Azria M, Herrmann FR, et al
    Nasal salmon calcitonin blunts bone microstructure alterations in healthy postmenopausal women.
    Osteoporos Int. 2015;26:383-93.
    PubMed     Text format     Abstract available


  420. STUCKEY BG, Sallie R
    Alendronate-induced unmasking or deterioration of coeliac disease: a case series.
    Osteoporos Int. 2015;26:411-4.
    PubMed     Text format    


  421. SILVERMAN S, Curtis J, Saag K, Flahive J, et al
    International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study.
    Osteoporos Int. 2015;26:419-20.
    PubMed     Text format    


  422. CHATTERJEE M, Hatori K, Duyck J, Sasaki K, et al
    High-frequency loading positively impacts titanium implant osseointegration in impaired bone.
    Osteoporos Int. 2015;26:281-90.
    PubMed     Text format     Abstract available


  423. ZHU TY, Griffith JF, Qin L, Hung VW, et al
    Density, structure, and strength of the distal radius in patients with psoriatic arthritis: the role of inflammation and cardiovascular risk factors.
    Osteoporos Int. 2015;26:261-72.
    PubMed     Text format     Abstract available


    October 2014
  424. ROBINSON PJ, Bell RJ, Zecena Morales CS, Fradkin P, et al
    Minimal-trauma fracture in women with breast cancer surviving for at least 5 years from diagnosis.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    September 2014
  425. MOLFINO A, Aversa Z, Muscaritoli M
    Cortisol and the muscle-bone axis.
    Osteoporos Int. 2014;25:2331-2.
    PubMed     Text format    


    August 2014
  426. SALE JE, Bogoch E, Hawker G, Gignac M, et al
    Patient perceptions of provider barriers to post-fracture secondary prevention.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    July 2014
  427. NELSON SD, Nelson RE, Cannon GW, Lawrence P, et al
    Cost-effectiveness of training rural providers to identify and treat patients at risk for fragility fractures.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  428. GIBSON-SMITH D, Klop C, Elders PJ, Welsing PM, et al
    The risk of major and any (non-hip) fragility fracture after hip fracture in the United Kingdom: 2000-2010.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  429. OMSLAND TK, Magnus JH
    Forecasting the burden of future postmenopausal hip fractures.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    June 2014
  430. DREW S, Sheard S, Chana J, Cooper C, et al
    Describing variation in the delivery of secondary fracture prevention after hip fracture: an overview of 11 hospitals within one regional area in England.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    May 2014
  431. HANSEN KE, Blank RD, Palermo L, Fink HA, et al
    What analytic method should clinicians use to derive spine T-scores and predict incident fractures in men? Results from the MrOS study.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    March 2014
  432. CANO A, Mendoza N, Sanchez-Borrego R
    Sequential use of antiresorptives in younger women.
    Osteoporos Int. 2014;25:1191-2.
    PubMed     Text format    


    February 2014
  433. DONNEAU AF, Reginster JY
    Cardiovascular safety of strontium ranelate: real-life assessment in clinical practice.
    Osteoporos Int. 2014;25:397-8.
    PubMed     Text format    


  434. ABRAHAMSEN B, Grove EL, Vestergaard P
    Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate.
    Osteoporos Int. 2014;25:757-62.
    PubMed     Text format     Abstract available


  435. SCILLITANI A, Mazziotti G, Di Somma C, Moretti S, et al
    Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?
    Osteoporos Int. 2014;25:441-6.
    PubMed     Text format     Abstract available


  436. HAGE MP, El-Hajj Fuleihan G
    Bone and mineral metabolism in patients undergoing Roux-en-Y gastric bypass.
    Osteoporos Int. 2014;25:423-39.
    PubMed     Text format     Abstract available


  437. MATEOS F, Valero C, Olmos JM, Casanueva B, et al
    Bone mass and vitamin D levels in women with a diagnosis of fibromyalgia.
    Osteoporos Int. 2014;25:525-33.
    PubMed     Text format     Abstract available


  438. MACINTYRE NJ, Lorbergs AL, Adachi JD
    Inclinometer-based measures of standing posture in older adults with low bone mass are reliable and associated with self-reported, but not performance-based, physical function.
    Osteoporos Int. 2014;25:721-8.
    PubMed     Text format     Abstract available


  439. PHAN V, Blydt-Hansen T, Feber J, Alos N, et al
    Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome.
    Osteoporos Int. 2014;25:627-37.
    PubMed     Text format     Abstract available


  440. BANG UC, Hyldstrup L, Jensen JE
    The impact of recombinant parathyroid hormone on malignancies and mortality: 7 years of experience based on nationwide Danish registers.
    Osteoporos Int. 2014;25:639-44.
    PubMed     Text format     Abstract available


  441. LAZARUS S, Zankl A, Duncan EL
    Next-generation sequencing: a frameshift in skeletal dysplasia gene discovery.
    Osteoporos Int. 2014;25:407-22.
    PubMed     Text format     Abstract available


  442. SHIN D, Kim S, Kim KH, Park SM, et al
    Importance of fat mass and lean mass on bone health in men: the Fourth Korean National Health and Nutrition Examination Survey (KNHANES IV).
    Osteoporos Int. 2014;25:467-74.
    PubMed     Text format     Abstract available


    December 2013
  443. ITO M, Oishi R, Fukunaga M, Sone T, et al
    The effects of once-weekly teriparatide on hip structure and biomechanical properties assessed by CT.
    Osteoporos Int. 2013.
    PubMed     Text format     Abstract available


    November 2013
  444. RAJAPAKSE CS , Phillips EA, Sun W, Wald MJ, et al
    Vertebral deformities and fractures are associated with MRI and pQCT measures obtained at the distal tibia and radius of postmenopausal women.
    Osteoporos Int. 2013.
    PubMed     Text format     Abstract available


    October 2013
  445. BOTTAI V , Giannotti S, Dell'osso G, De Paola G, et al
    Atypical femoral fractures: retrospective radiological study of 319 femoral fractures and presentation of clinical cases.
    Osteoporos Int. 2013.
    PubMed     Text format     Abstract available


    September 2013
  446. EEKMAN DA , van Helden SH, Huisman AM, Verhaar HJ, et al
    Optimizing fracture prevention: the fracture liaison service, an observational study.
    Osteoporos Int. 2013.
    PubMed     Text format     Abstract available


    July 2013
  447. ACU K , Scheel M, Issever AS
    Time dependency of bone density estimation from computed tomography with intravenous contrast agent administration.
    Osteoporos Int. 2013.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: